Treatment of acute lymphoblastic leukemia in children and adolescents: peaks and pitfalls.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2008, Pages 374-380

  Seibel, Nita L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; MERCAPTOPURINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; CHILD; DIPLOIDY; DISEASE FREE SURVIVAL; GENETICS; HUMAN; MORTALITY; REMISSION; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; DIPLOIDY; DISEASE-FREE SURVIVAL; HUMANS; METHOTREXATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67651167100     PISSN: 15204391     EISSN: None     Source Type: Journal    
DOI: 10.1182/asheducation-2008.1.374     Document Type: Review

References (45)